Caval chemodectoma in a cat
Open Access
- 5 July 2022
- journal article
- research article
- Published by SAGE Publications in Journal of Feline Medicine and Surgery Open Reports
- Vol. 8 (2)
Abstract
Case summary: An 11-year-old male neutered domestic shorthair cat was presented with a 4-week history of an intermittent cough and dyspnoea. A pleural effusion was identified, which was confirmed as chyle. Echocardiography and CT revealed a 16 mm mass cranial to the heart, which was invading the cranial vena cava. Because of the location of the mass, it was assumed that chylothorax had developed as a result of direct disruption of the thoracic duct by the tumour or secondarily to central venous hypertension. An exploratory thoracotomy was performed, and the mass, which originated within the wall of the cranial vena cava, was excised with narrow gross margins. Histopathology and immunohistochemistry were consistent with a chemodectoma with residual tumour cells at the surgical margin. Given the residual microscopic disease, adjuvant treatment with toceranib phosphate was initiated. The cat remained well for the duration of treatment and was euthanased 31 months after diagnosis when CT identified recurrent pleural effusion, a heart base mass with cranial vena cava and azygos vein invasion. Relevance and novel information: Chemodectomas are rare in cats, with only 13 cases reported in the literature to date, and all were located in either the aortic or carotid body. The reported survival with partial resection and/or subtotal pericardiectomy was 13–19 months. Treatment of feline chemodectomas with toceranib phosphate has not been previously reported. To our knowledge, this is the first description of the surgical management of a feline vena cava chemodectoma, combined with adjuvant toceranib phosphate, resulting in a prolonged survival.Keywords
This publication has 24 references indexed in Scilit:
- Surgical management of a neuroendocrine tumor of the inferior vena cavaJournal of Vascular Surgery, 2013
- Histopathological and Immunohistochemical Evaluation of Malignant Potential in Canine Aortic Body TumoursJournal of Comparative Pathology, 2013
- Genetics and molecular pathogenesis of pheochromocytoma and paragangliomaClinical Endocrinology, 2013
- Pheochromocytoma and paraganglioma: understanding the complexities of the genetic backgroundCancer Genetics, 2012
- Preliminary evidence for biologic activity of toceranib phosphate (Palladia®) in solid tumoursVeterinary and Comparative Oncology, 2011
- Pathologic and Immunohistochemical Findings in a Feline Aortic Body TumorVeterinary Pathology, 2004
- Intrathoracic Mass in a CatVeterinary Clinical Pathology, 2002
- Analysis of Factors Affecting Survival in Dogs With Aortic Body TumorsVeterinary Surgery, 2002
- An aortic body carcinoma with multifocal thoracic metastases in a catJournal of Comparative Pathology, 1989
- CT evaluation of mediastinal massesComputerized Radiology, 1987